| dc.description.abstract |
Transition metal complexes are endowed with properties suitable for inhibition of bacterial
infectious diseases. Based on this, identification and synthesis of new transition metal complexes
is a passion for scientists. In this report copper (II) homobinuclear mixed ligand complexes
containing resorcinolate (R), acetone (Ac) and ethylenediamine (en) with formula H4[Cu2(R2-
)2(R-)4], H4[Cu2(R2-)2(R-)4Ac2], H8[Cu2(R2-)6en], H8[Cu2(R2-)6en2], H4[Cu2(R2-)2(R-)4enAc], and
Na8[Cu2(R2-)6] were synthesized. The structures of the synthesized complexes were characterized
using various analytical, electrochemical and spectroscopic techniques, particularly using UVVis,
FT-IR, ICP-OES, CV, Molar conductivity, pH, Melting point, Qualitative chloride test and
Solubility tests. Furthermore, the synthesized complexes were evaluated for their in vitro
antibacterial activities against some Gram-positive (Staphyloccus aureus and Streptococcus
pyogens) and Gram-negative (Escherichia coli, Klebsiella Pneumonia) bacterial species by disc
diffusion method and the result obtained were compared with the commercially available drug
gentamicin by calculating percent activity index. The complexes were found to be active against
all the tested bacteria. According to the percent activity index data, most complexes have higher
antibacterial activity than gentamicin even in gram-negative bacterial strains. So, after the in
vivo cyto toxicity investigation, per-clinical and clinical tests the newly synthesized complexes
could be considered as potential antimicrobial agent. |
en_US |